Is the agency suggesting that there are benefits of testing Ashkenazi Jewish BRCA mutations in non-Jewish women? How does the FDA justify that the benefits of testing outweigh the known risks? Well, ...

The FDA made a point to note that there are more than 1,000 cancer-related mutations in BRCA genes, and just about 2 percent of Ashkenazi Jewish women carry the three mutations in the test. They are ...

such as patients with BRCA mutations. Testing new, emerging biologic therapies will also further refine the best uses for the test.

NHS England is rolling out a national BRCA gene testing ... offered a simple saliva test. Saliva samples are collected by people in their own homes and then sent to a lab for testing.

In another area of the lab, FedEx packages fill big, rolling mailing bins. Inside each package is one person's test kit with blood to be analyzed. That's just half a day's worth of tests ...

“That’s more patients who find out that they have a BRCA mutation and can ... They can then give consent and go to the lab without delay or have a saliva test kit sent to their home.

Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.